Literature DB >> 20621793

Human detoxification of perfluorinated compounds.

S J Genuis1, D Birkholz, M Ralitsch, N Thibault.   

Abstract

There has been no proven method thus far to accelerate the clearance of potentially toxic perfluorinated compounds (PFCs) in humans. PFCs are a family of commonly used synthetic compounds with many applications, including repelling oil and stains on furniture, clothing, carpets and food packaging, as well as in the manufacturing of polytetrafluoroethylene - a non-stick surfacing often used in cookware (e.g. Teflon(r)). Some PFCs remain persistent within the environment due to their inherent chemical stability, and are very slowly eliminated from the human body due, in part, to enterohepatic recirculation. Exposure to PFCs is widespread and some subpopulations, living in proximity to or working in fluorochemical manufacturing plants, are highly contaminated. PFC bioaccumulation has become an increasing public health concern as emerging evidence suggests reproductive toxicity, neurotoxicity and hepatotoxicity, and some PFCs are considered to be likely human carcinogens. A case history is presented where an individual with high concentrations of PFCs in serum provided: (1) sweat samples after use of a sauna; and (2) stool samples before and after oral administration of each of two bile acid sequestrants - cholestyramine (CSM) and saponin compounds (SPCs). Stool samples before and after use of a cation-exchange zeolite compound were also examined. PFCs found in serum were not detected in substantial quantities in sweat or in stool prior to treatment. Minimal amounts of perfluorooctanoic acid, but no other PFCs, were detected in stool after SPC use; minimal amounts of perfluorooctanesulfonate, but no other PFCs, were detected in stool after zeolite use. All PFC congeners found in serum were detected in stool after CSM use. Serum levels of all PFCs subsequently declined after regular use of CSM. Further study is required but this report suggests that CSM therapy may facilitate gastrointestinal elimination of some PFCs from the human body. Copyright 2010 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621793     DOI: 10.1016/j.puhe.2010.03.002

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  16 in total

1.  Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats.

Authors:  Wen Zhao; Jeremiah D Zitzow; David J Ehresman; Shu-Ching Chang; John L Butenhoff; Jameson Forster; Bruno Hagenbuch
Journal:  Toxicol Sci       Date:  2015-05-21       Impact factor: 4.849

2.  Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Abby F Fleisch; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2019-05-28       Impact factor: 9.621

3.  Organic Anion Transporting Polypeptides Contribute to the Disposition of Perfluoroalkyl Acids in Humans and Rats.

Authors:  Wen Zhao; Jeremiah D Zitzow; Yi Weaver; David J Ehresman; Shu-Ching Chang; John L Butenhoff; Bruno Hagenbuch
Journal:  Toxicol Sci       Date:  2017-03-01       Impact factor: 4.849

Review 4.  Arsenic, cadmium, lead, and mercury in sweat: a systematic review.

Authors:  Margaret E Sears; Kathleen J Kerr; Riina I Bray
Journal:  J Environ Public Health       Date:  2012-02-22

Review 5.  Environmental determinants of chronic disease and medical approaches: recognition, avoidance, supportive therapy, and detoxification.

Authors:  Margaret E Sears; Stephen J Genuis
Journal:  J Environ Public Health       Date:  2012-01-19

6.  Phlebotomy treatment for elimination of perfluoroalkyl acids in a highly exposed family: a retrospective case-series.

Authors:  Stephen J Genuis; Yanna Liu; Quentin I T Genuis; Jonathan W Martin
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

7.  Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water.

Authors:  Ying Li; Tony Fletcher; Daniel Mucs; Kristin Scott; Christian H Lindh; Pia Tallving; Kristina Jakobsson
Journal:  Occup Environ Med       Date:  2017-11-13       Impact factor: 4.402

8.  Gastrointestinal Elimination of Perfluorinated Compounds Using Cholestyramine and Chlorella pyrenoidosa.

Authors:  Stephen J Genuis; Luke Curtis; Detlef Birkholz
Journal:  ISRN Toxicol       Date:  2013-09-09

9.  Biomonitoring and Elimination of Perfluorinated Compounds and Polychlorinated Biphenyls through Perspiration: Blood, Urine, and Sweat Study.

Authors:  Stephen J Genuis; Sanjay Beesoon; Detlef Birkholz
Journal:  ISRN Toxicol       Date:  2013-09-03

10.  Association between perfluoroalkyl acids and kidney function in a cross-sectional study of adolescents.

Authors:  Anglina Kataria; Howard Trachtman; Laura Malaga-Dieguez; Leonardo Trasande
Journal:  Environ Health       Date:  2015-11-21       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.